SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (29633)12/14/1999 11:57:00 AM
From: bob zagorin  Read Replies (1) | Respond to of 32384
 
well, i was surprised by the negative comments on the "flaws" in the trials and the request for additional studies. but then i don't know the company as well as you. again, i do think the primary emphasis should be on the positive approval.



To: Henry Niman who wrote (29633)12/14/1999 5:45:00 PM
From: notyet  Read Replies (1) | Respond to of 32384
 
What is the current treatment for early-stage-CTLC?
How many of the early-stage-patients advance ?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News